Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: A 24-week, randomized, open-label, follow-up study in China

Clinical Therapeutics

Volumn 32, Issue 4, 2010, Pages 692-700

  Zou, Li Ping ^a,b   Wang, Xu ^b   Dong, Chang Hong ^b   Chen, Chun Hong ^b   Zhao, Wei ^b   Zhao, Ruo Yan ^c  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

ACTH; Infantile spasms; Magnesium sulfate; Therapy

Indexed keywords

CORTICOTROPIN; MAGNESIUM SULFATE;

ADAPTATION; ANOREXIA; ARTICLE; CHINA; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FEMALE; FEVER; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; INFANTILE SPASM; INSOMNIA; IRRITABILITY; LANGUAGE ABILITY; MALE; MONOTHERAPY; MOTOR PERFORMANCE; NERVE CELL DIFFERENTIATION; OPEN STUDY; OUTCOME ASSESSMENT; PR INTERVAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SOCIAL ADAPTATION; SOCIAL EVOLUTION; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

ADRENOCORTICOTROPIC HORMONE; CHINA; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HORMONES; HUMANS; INFANT; MAGNESIUM SULFATE; MALE; PSYCHOMOTOR PERFORMANCE; RECEPTORS, N-METHYL-D-ASPARTATE; SPASMS, INFANTILE;

EID: 77952484854     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.04.008     Document Type: Article

References (26)

1. Cowan LD, Hudson LS The epidemiology and natural history of infantile spasms. J Child Neurol 1991, 6:355-364.
2. Lux AL, Osborne JP The influence of etiology upon ictal semiology, treatment decisions and long-term outcomes in infantile spasms and West syndrome. Epilepsy Res 2006, 70(Suppl 1):S77-S86.
3. Bradford HF Glutamate, GABA and epilepsy. ProgNeurobiol 1995, 47:477-511.
4. Herlenius E, Lagercrantz H Development of neurotransmitter systems during critical periods. Exp Neurol 2004, 190(Suppl 1):S8-S21.
5. Kábová R, Liptáková S, Slamberová R, et al. Age-specific N-methyl -D-aspartate-induced seizures: Perspectives for the West syndrome model. Epilepsia 1999, 40:1357-1369.
6. Mackay MT, Weiss SK, Adams-Webber T, et al. Practice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology Society. Neurolog 2004, 62:1668-1681. for the American Academy of Neurology, Child Neurology Society.
7. Riikonen R, Donner M ACTH therapy in infantile spasms: Side effects. Arch Dis Child 1980, 55:664-672.
8. Okuno T, Ito M, Konishi Y, et al. Cerebral atrophy following ACTH therapy. J Comput Assist Tomogr 1980, 4:20-23.
9. Vigevano F, Cilio MR Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study. Epilepsia 1997, 38:1270-1274.
10. Glauser TA, Clark PO, McGee K Long-term response to topiramate in patients with West syndrome. Epilepsia 2000, 41(Suppl 1):S91-S94.
11. Zou LP, Lin Q, Qin J, et al. Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms. Clin Neuropharmacol 2008, 31:86-92. for the Topiramate Study Group.
12. Zou LP, Ding CH, Fang F, et al. Prospective study of first-choice topiramate therapy in newly diagnosed infantile spasms. Clin Neuropharmacol 2006, 29:343-349.
13. Hrachovy RA, Frost JD Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 2003, 20:408-425.
14. Nabbout R A risk-benefit assessment of treatments for infantile spasms. DrugSaf 2001, 24:813-828.
15. Zupanc ML Infantile spasms. Expert Opin Pharmacother 2003, 4:2039-2048.
16. Hallak M, Berman RF, Irtenkauf SM, et al. Peripheral magnesium sulfate enters the brain and increases the threshold for hippocampal seizures in rats. Am J Obstet Gynecol 1992, 167:1605-1610.
17. Rouse DJ Magnesium sulfate for the prevention of cerebral palsy. Am J Obstet Gynecol 2009, 200:610-612.
18. Moser J, Kilb W, Werhahn KJ, Luhmann HJ Early developmental alterations of low-Mg2+-induced epileptiform activity in the intact corticohippocampal formation of the newborn mouse in vitro. Brain Res 2006, 1077:170-177.
19. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399. Commission on Classification and Terminology of the International League Against Epilepsy.
20. Groenendaal F, Rademaker CM, Toet MC, de Vries LS Effects of magnesium sulphate on amplitude integrated continuous EEG in asphyxiated term neonates. Acta Paediatr 2002, 91:1073-1077.
21. Snead OC, Benton JW, Hosey LC, et al. Treatment of infantile spasms with high-dose ACTH: Efficacy and plasma levels of ACTH and cortisol. Neurology 1989, 39:1027-1031.
22. Cao HY, Jiang YW, Liu ZW, Wu XR Effect of recurrent epileptiform discharges induced by magnesium-free treatment on developing cortical neurons in vitro. Brain Res Dev Brain Res 2003, 142:1-6.
23. Crowther CA, Hiller JE, Doyle LW, Haslam RR Effect of magnesium sulfate given for neuroprotection before preterm birth: A randomized controlled trial. JAMA 2003, 290:2669-2676. for the Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group.
24. Euser AG, Bullinger L, Cipolla MJ Magnesium sulphate treatment decreases blood-brain barrier permeability during acute hypertension in pregnant rats. Exp Physiol 2008, 93:254-261.
25. Spandou E, Soubasi V, Papoutsopoulou S, et al. Neuroprotective effect of long-term MgSO4 administration after cerebral hypoxia-ischemia in newborn rats is related to the severity of brain damage. Reprod Sci 2007, 14:667-677.
26. Goñi-de-Cerio F, Alvarez A, Alvarez FJ, et al. MgSO4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules. Histol Histopathol 2009, 24:1129-1138.